Company: NIVFW
Filing Date: 2025-10-10
Form Type: F-1/A
Source: 0001213900-25-098135
Chunk: 107

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-10
Form: F-1/A
Chunk 107
---
 amount due to Mr. Siu and Ms. Fong was US$92,651. As of June 30, 2025, the aggregate balance of amount due from Mr. Siu, Ms. Fong and Harcourt Limited was US$382,687 and will be paid back before end of 2025. In addition, NewGenIvf also recorded remuneration to its directors, Mr. Siu and Ms. Fong. The remuneration to Mr. Siu, Wing Fung Alfred was US$125,000 and US$190,000 during the year ended December 31, 2023 and 2024, respectively. The remuneration during the years ended December 31, 2023 and 2024 was all in the nature of the fair value of the services provided by Mr. Siu and Ms. Fong. Mr. Siu Wing Fung also entered into agreement to waive the balance of due from the Company US$88,151 in 2023. 61 LISTING DETAILS Our Class A Ordinary Shares currently trade on Nasdaq under the symbol “NIVF.” As of the date of this prospectus, our only listed class of securities are our Class A Ordinary Shares. All of our Class A Ordinary Shares, including those to be offered by the Selling Securityholder pursuant to this prospectus, have the same rights and privileges. For more information, see “ Description of Share Capital—Ordinary Shares.” USE OF PROCEEDS All of the Resale Shares will be sold by the Selling Securityholders for their own accounts. We will not receive any proceeds from the resale of the Resale Shares. However, we may receive gross proceeds of up to $500 million from the sale of our Ordinary Shares to White Lion pursuant to the White Lion Purchase Agreement. We expect to use such proceeds for working capital and other general corporate purposes. The actual proceeds from White Lion may be less than this amount, depending on the number of Class A Ordinary Shares sold and the price at which the Class A Ordinary Shares are sold. In addition, we may receive proceeds of up to $42,443,500 from the conversion of the Additional Notes, Exchange Notes, Warrants, New CB Initial Note which proceeds will be used for working capital and other general corporate purposes. We will also bear the costs incurred in connection with this prospectus and the registration of the Resale Shares. DIVIDEND POLICY We have not declared or paid any cash dividend on our Class A Ordinary Shares